In this report the authors found that homozygous deletions of the SMN2 gene were 4 times more frequent in ALS patients than in controls (16% = 18/110 patients vs. 4% = 4/100 patients). This evidence concerns the gene SMN2 and amyotrophic lateral sclerosis.